Skip to main content
. Author manuscript; available in PMC: 2013 Jul 12.
Published in final edited form as: J Med Chem. 2012 Jun 25;55(13):6047–6060. doi: 10.1021/jm300123s

Table 1.

Antitubercular activity of different scaffolds of bioreductively-activated antimicrobial compounds.

Classification Compound LUMO (eV) TB MIC – SRI (μg/mL) TB MIC –ITR (μg/mL) LORA MIC – ITR (μg/mL) Vero Tox CC50 (μg/mL) SI (CC50/MIC)
Isoniazid INH 0.060 0.091 >20 >50 >830
Rifampin RIF 0.003 0.041 2.0 >50 >15000
Nitroimidazole Metronidazole −1.303 >10 >32 11 >16 NA
Etanidazole −1.644 >10 >32 26 >16 NA
1 −1.802 10 29 3.3 16 1.6
Nitrofurans Nitrofurantoin −1.801a 16 28 32 23 1.1
Furazolidone −1.652a 31 30 6.5 19 0.60
2 −1.660a 0.98 3.8 3.7 >50 >50
Quinoxaline-1,4-di-N-oxides 3 −1.452 10 28 9.4 >16 >1.6
4 −2.436 >20 >32 >32 >16 NA
5 −1.919 10 27 >32 >16 >1.6
6 −1.279 >10 >32 >32 >16 NA
Benzotriazine-1,4-di-N-oxides TPZ −1.622 5.0 3.7 7.3 8.0 1.6
7 −1.703 5.0 3.7 0.97 38 7.6
8a −1.442 1.2 0.57 0.37 17 17
a

Calculation performed for Z stereochemistry around double bond.

NA = not available; ITR = Institute for Tuberculosis Research, University of Illinois at Chicago.